May 8, 2025 - 02:24
PALM BEACH GARDENS, Fla., May 7, 2025 — Great Elm Group, Inc. has released its financial results for the third quarter of the fiscal year ending March 31, 2025. The company continues to demonstrate its growth and expansion within the alternative asset management sector.
In a notable development, Great Elm acquired the assets of Greenfield CRE in February 2025, leading to the formation of Monomoy Construction Services, LLC (MCS). This strategic move is expected to enhance the company's service offerings and bolster its position in the market.
The financial report highlights the company's ongoing commitment to diversifying its portfolio and maximizing shareholder value. As part of its transparency efforts, Great Elm will host a conference call at 8:30 a.m. ET on May 8, 2025, to discuss these results in detail and outline future strategies.
Investors and stakeholders are encouraged to participate in the call to gain insights into the company's performance and upcoming initiatives.
September 22, 2025 - 01:42
Dollar Steady as Traders Anticipate Fed Officials' SpeechesSINGAPORE - The dollar maintained its stability on Monday, as market participants geared up for a series of speeches from Federal Reserve officials scheduled for the week. These discussions are...
September 21, 2025 - 19:09
ICL Group's Stock Struggles Despite Promising Financial OutlookIt is hard to get excited after looking at ICL Group`s recent performance, as its stock has declined by 9.2% over the past few months. This downturn has raised eyebrows among investors, prompting...
September 21, 2025 - 05:37
Mortgage Rates Rise Following Federal Reserve Rate CutMortgage rates have experienced a slight increase following the recent decision by the Federal Reserve to cut rates. This upward movement, while notable, keeps mortgage rates within proximity to...
September 20, 2025 - 23:13
Latest Developments on Trump's TariffsYahoo Finance is chronicling the latest news and updates on Trump`s tariffs. In a significant statement, Swiss drugmaker Novartis has expressed confidence in its ability to withstand potential...